JWResearcher profile · from public sources
Jia Wu
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer.
Journal for immunotherapy of cancer, Sept 2026
Publication
The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, Jul 2026
Publication
Author Correction: Innovative approaches for lung cancer screening and interception.
Nature reviews. Clinical oncology, May 2026
Publication
Innovative approaches for lung cancer screening and interception.
Nature reviews. Clinical oncology, Feb 2026
Publication
Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer.
European radiology, Dec 2025
Publication
Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre-cancer lesions.
International journal of cancer, Dec 2025
Publication
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.
Cancers, Nov 2025
Publication
First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research, Nov 2025
Publication
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients.
Cancers, Oct 2025
Publication
Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial.
Journal for immunotherapy of cancer, Oct 2025
Publication
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity.
Nature communications, Sept 2025
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Xiuning Le directly.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error